Patents by Inventor Christina Erb

Christina Erb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8076355
    Abstract: The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: December 13, 2011
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Martin Hendrix, Frank-Gerhard Böβ, Christina Erb, Timo Fleβner, Marja Van Kampen, Joachim Luithle, Christoph Methfessel, Welf-Burkhard Wiese
  • Publication number: 20110294834
    Abstract: The invention relates to novel alkyl-substituted pyrazolopyrimidines, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: July 29, 2011
    Publication date: December 1, 2011
    Inventors: Martin HENDRIX, Frank-Gerhard Böß, Nils Burkhardt, Christina Erb, Adrian Tersteegen, Marja Van Kampen
  • Publication number: 20110263591
    Abstract: The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: July 11, 2011
    Publication date: October 27, 2011
    Applicant: Bayer Schering Pharma AG
    Inventors: Joachim Luithle, Frank-Gerhard Böss, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Timo Flessner, Marja van Kampen, Franz-Josef van der Staay
  • Patent number: 8044060
    Abstract: Described are 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolo[3,4-d]pyrimidines of the formula (I): as defined herein, processes for their preparation and their use for producing medicaments for treating impairment of perception, concentration, learning and/or memory.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: October 25, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Hendrix, Lars Bärfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Patent number: 8039477
    Abstract: The invention relates to novel alkyl-substituted pyrazolopyrimidines, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory with compounds of formula (I):
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: October 18, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Hendrix, Frank-Gerhard Böβ, Nils Burkhardt, Christina Erb, Adrian Tersteegen, Marja Van Kampen
  • Patent number: 7977485
    Abstract: The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: July 12, 2011
    Assignee: Bayer Schering Pharma Aktiengesellshaft
    Inventors: Joachim Luithle, Frank-Gerhard Böβ, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Timo Fleβner, Marja van Kampen, Franz-Josef van der Staay
  • Publication number: 20110065730
    Abstract: The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: November 19, 2010
    Publication date: March 17, 2011
    Inventors: Martin Hendrix, Lars Bärfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Publication number: 20100324085
    Abstract: The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.
    Type: Application
    Filed: August 30, 2010
    Publication date: December 23, 2010
    Applicant: Bayer Schering Pharma AG
    Inventors: Timo Flessner, Frank-Gerhard Böss, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Dieter Lang, Joachim Luithle, Maria-Van Kampen, Franz-Josef Van der Staay
  • Patent number: 7795453
    Abstract: The invention relates to novel benzothiophene-, benzofuran- and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: September 14, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Timo Fleβner, Frank-Gerhard Böβ, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Dieter Lang, Joachim Luithle, Marja Van Kampen, Franz-Josef Van der Staay
  • Publication number: 20100222378
    Abstract: The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: May 11, 2010
    Publication date: September 2, 2010
    Applicant: Bayer Schering Pharma AG
    Inventors: Martin Hendrix, Frank-Gerhard Böß, Christina Erb, Timo Fleßner, Marja Van Kampen, Joachim Luithle, Christoph Methfessel, Welf-Burkhard Wiese
  • Publication number: 20100210839
    Abstract: The invention relates to the use of selective phosphodiesterase 9A (PDE9A) inhibitors for producing medicaments for improving perception, concentration, cognitive processes, learning and/or memory.
    Type: Application
    Filed: April 28, 2010
    Publication date: August 19, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Frank-Gerhard Böss, Christina ERB, Matin HENDRIX, Marja VAN KAMPEN, Frank WUNDER
  • Patent number: 7737156
    Abstract: The invention relates to the use of selective phosphodiesterase 9A (PDE9A) inhibitors for producing medicaments for improving perception, concentration, cognitive processes, learning and/or memory.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: June 15, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank-Gerhard Böβ, Christina Erb, Martin Hendrix, Marja van Kampen, Frank Wunder
  • Patent number: 7732477
    Abstract: The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: June 8, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Martin Hendrix, Frank-Gerhard Böβ, Christina Erb, Timo Fleβner, Marja van Kampen, Joachim Luithle, Christoph Methfessel, Welf-Burkhard Wiese
  • Publication number: 20100035900
    Abstract: The invention relates to novel 6-arylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: October 16, 2009
    Publication date: February 11, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Martin HENDRIX, Lars Bärfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Patent number: 7615558
    Abstract: Described are 6-arylmethylpyrazolo[3,4-d]pyrimidines of the following formula: processes for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Grant
    Filed: April 27, 2004
    Date of Patent: November 10, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Hendrix, Lars Bärfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Publication number: 20090258898
    Abstract: The invention relates to novel amides of acetic and propionic acids, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.
    Type: Application
    Filed: June 29, 2009
    Publication date: October 15, 2009
    Applicant: Bayer Healthcare AG
    Inventors: Joachim Luithle, Frank-Gerhard Bob, Christina Erb, Katrin Schnitzler, Timo Flessner, Marja Van Kampen, Christoph Methfessel
  • Patent number: 7553851
    Abstract: The invention relates to novel amides of acetic and propionic acids, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: June 30, 2009
    Assignee: Bayer Healthcare AG
    Inventors: Joachim Luithle, Frank-Gerhard Böβ, Christina Erb, Katrin Schnizler, Timo Fleβner, Marja van Kampen, Christoph Methfessel
  • Publication number: 20090111838
    Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
    Type: Application
    Filed: December 19, 2008
    Publication date: April 30, 2009
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Martin HENDRIX, Lars BARFACKER, Bettina BEYREUTHER, Ulrich EBERT, Christina ERB, Frank-Thorsten HAFNER, Heike HECKROTH, Yan-Hong LIU, Dagmar KARTHAUS, Adrian TERSTEEGEN, Franz-Josef VAN DER STAAY, Marja VAN KAMPEN
  • Patent number: 7488733
    Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: February 10, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Hendrix, Lars Bärfacker, Bettina Beyreuther, Ulrich Ebert, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Yan-Hong Liu, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Publication number: 20080009624
    Abstract: The invention relates to novel heteroaryl carboxamides, a process for their preparation, and pharmaceutical compositions containing them. These materials are useful for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: August 10, 2007
    Publication date: January 10, 2008
    Applicant: Bayer Healthcare AG
    Inventors: Martin Hendrix, Frank-Gerhard Boss, Christina Erb, Joachim Kruger, Joachim Luithle, Christoph Methfessel, Rudy Schreiber, Welf-Burkhard Wiese